Brassicaceae selenium complexes versus SARS-COV-2 MAP4 and spike protein


J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 514-525, May-Jun 2024. DOI: Original Article Antiviral potential of selenium complexes from Brassicaceae by inhibiting protein bond between MAP4 and the spike of SARS-CoV-2 [Potencial antiviral de complejos de selenio de Brassicaceae mediante la inhibición de la unión proteica entre MAP4 y la espiga de … Continue reading Brassicaceae selenium complexes versus SARS-COV-2 MAP4 and spike protein

J. Pharm. Pharmacogn. Res., vol. 12, no. 3, pp. 514-525, May-Jun 2024.


Original Article

Antiviral potential of selenium complexes from Brassicaceae by inhibiting protein bond between MAP4 and the spike of SARS-CoV-2

[Potencial antiviral de complejos de selenio de Brassicaceae mediante la inhibición de la unión proteica entre MAP4 y la espiga de SARS-CoV-2]

Silvi Z. Ilmiyah1, Sharida Fakurazi2, Agustina T. Endharti3,4, Sofy Permana5*

1Master Program in Biomedical Science, Faculty of Medicine, Universitas Brawijaya Malang, Indonesia.

2Department of Human Anatomy, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, Selangor Daru I Ehsan, Malaysia.

3Department of Parasitology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

4Biomedical Central Laboratory, Faculty of Medicine, Universitas Brawijaya Malang, Indonesia.

5Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Brawijaya, Malang, Indonesia.



Context: Coronavirus disease 2019 (COVID-19), a highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic. Selenium derived from the plants of the Brassicaceae family plays an important role in several biological functions, often as an antioxidant or antiviral. In particular, selenium can be used as an adjuvant in the treatment of various viral infections.

Aims: To determine the potential drug, as well as the affinity and the bond energy associated with chemical interaction bonds between the complex selenium compounds from Brassicaceae as inhibitors of the SARS-CoV-2 spike protein and MAP4 through the use of in silico studies.

Methods: The methods used in this study consisted of receptor and ligand data collection, ADMET analysis, molecular docking, and molecular dynamics.

Results: The results of this study indicate that the selenium complex compounds have the potential to be used as a spike inhibitor drug for SARS-CoV-2, as they have passed the Lipinski test and showed promise in the pharmacokinetic analysis. The results of the bond docking show that several complex selenium compounds, such as ethaselen, selenomethionine, and selenocystine, have stronger binding affinity values than the controls. This is compared to the control MAP4, which yielded binding affinities of -6.1 kcal/mol and spike protein -7 kcal/mol, respectively. Controlled bisoxatin and estramustine are drugs with mechanisms targeted to MAP4 and spike protein, which are the usual standards used.

Conclusions: The similarity of sites, the binding of several amino acid residues dominated by hydrogen bonds, and the result of molecular dynamic results for the selenium compound derived from Brassicaceae showed a stable bond to the spike protein and MAP4 with low fluctuation levels.

Keywords: MAP4; SARS-CoV-2; selenium; spike protein.

PDF Download


Contexto: La enfermedad por coronavirus 2019 (COVID-19), una enfermedad vírica altamente contagiosa por coronavirus de tipo 2 causante del síndrome respiratorio agudo severo (SARS-CoV-2), se ha convertido en una pandemia mundial. El selenio derivado de las plantas de la familia Brassicaceae desempeña un papel importante en varias funciones biológicas, a menudo como antioxidante o antiviral. En particular, el selenio puede utilizarse como coadyuvante en el tratamiento de diversas infecciones virales.

Objetivos: Determinar el fármaco potencial, así como la afinidad y la energía de enlace asociada a los enlaces de interacción química entre los compuestos complejos de selenio de Brassicaceae como inhibidores de la proteína espiga del SARS-CoV-2 y MAP4 mediante el uso de estudios in silico.

Métodos: Los métodos utilizados en este estudio consistieron en la recopilación de datos de receptores y ligandos, análisis ADMET, docking molecular y dinámica molecular.

Resultados: Los resultados de este estudio indican que los compuestos del complejo de selenio tienen potencial para ser utilizados como fármaco inhibidor de picos para el SARS-CoV-2, ya que han superado el test de Lipinski y se han mostrado prometedores en el análisis farmacocinético. Los resultados del acoplamiento de enlaces muestran que varios compuestos complejos de selenio, como el etaseleno, la selenometionina y la selenocisteína, tienen valores de afinidad de enlace más fuertes que los controles. Esto se compara con el MAP4 de control, que arrojó afinidades de unión de -6,1 kcal/mol y proteína pico -7 kcal/mol, respectivamente. La bisoxatina y la estramustina controladas son fármacos con mecanismos dirigidos a MAP4 y spike protein, que son los patrones habituales utilizados.

Conclusiones: La similitud de los sitios, la unión de varios residuos de aminoácidos dominados por enlaces de hidrógeno, y el resultado de los resultados de dinámica molecular para el compuesto de selenio derivado de Brassicaceae mostraron una unión estable a la proteína espiga y MAP4 con bajos niveles de fluctuación.

Palabras Clave: MAP4; SARS-CoV-2; selenio; proteína espiga.

PDF Download


Citation Format: Ilmiyah SZ, Fakurazi S, Endharti AT, Permana S (2024) Antiviral potential of selenium complexes from Brassicaceae by inhibiting protein bond between MAP4 and the spike of SARS-COV-2. J Pharm Pharmacogn Res 12(3): 514–525.

Aminpour M, Hameroff S, Tuszynski JA (2022) How COVID-19 hijacks the cytoskeleton: Therapeutic implications. Life (Basel) 12(6): 814.

Boopathi S, Poma AB, Kolandaivel P, Novel (2019) coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn 39(9): 3409–3418.

Chauhan R, Awasthi S, Srivastava S, Dwivedi S, Pilon-Smits EAH, Dhankher OP, Rudra D (2019) Understanding selenium metabolism in plants and its role as a beneficial element. Crit Rev Environ Sci Tech 49(21): 1937–1958.

Chinnasamy SG, Selvaraj AC, Kaushik S, Kaliamurthi C, Selvaraj SK, Singh R, Thirugnanasambandam K, Gu A, Wei DQ (2019) Molecular docking and molecular dynamics simulation studies to identify potent AURKA inhibitors: Assessing the performance of density functional theory, MM-GBSA and mass action kinetics calculations. J Biomol Struct Dyn 38(14): 4325–4335.

Collier TA, Piggot TJ, Allison JR (2019) Molecular dynamics simulation of protein. In: Gerrard J, Domigan L (eds) Protein Nanotechnology. Methods in Molecular Biology, vol 2073. New York, NY: Humana, pp. 311–327.

Endharti AT, Wahyuningtyas TE, Hardini KH, Widjajanto E, Permana S (2018) Dendrophthoe pentandra leaves extract promotes apoptotic effects of doxorubicin in human breast cancer cell via modulation of intracellular calcium and survivin. J Appl Pharm Sci 8(8): 39–43.

Fedorov VA, Orekhov PS, Kholina EG, Gudimchuk NB (2019) Mechanical properties of tubulin intra- and inter-dimer interfaces and their implications for microtubule dynamic instability. PloS Comput Biol 18: 14–21.

Ghosh S, Dellibovi TA, Kerviel A, Pak E, Qiu Q, Fisher M, Takvorian PM, Bleck C, Hsu VW, Fehr AR (2020) β-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell 83: 1520–1535.e14.

Gudimchuk NB, McIntosh JR (2021) Regulation of microtubule dynamics, mechanics and function through the growing tip. Nat Rev Mol Cell Biol 22: 777–795.

Hollingsworth SA, Dror RO (2019) Molecular dynamics simulation for all. Neuron 99(6): 1129–1143.

Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H (2020) The architecture of SARS-CoV-2 transcriptome. Cell 181: 914–921.

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 55(3): 105924.

Mawaddani N, Wibowo NRK, Nadhira QHH, Pramifta RA (2020) In silico study of Centella asiatica compund as BACE1 inhibitor in Alzheimer’s disease. J Smart Bioprosp Technol 1(2): 36–40.

Permana S, Fityanti PR, Norahmawati E, Iskandar A, Mulyadi AED, Endharti TA (2020) Coelomic fluid of Eisenia fetida ameliorates cetuximab to reduce K-Ras and vimentin expression through promoting RUNX3 in an AOM/DSS-induced colitis associated colon cancer. Evid Based Complement Alternat Med 2020: 9418520.

Rakib A, Nain Z, Sami SA, Mahmud S, Islam A, Ahmed S, Siddiqui ABF, Babu SMOF, Hossain P, Shahriar A, Nainu F, Emran TB, Simal-Gandara J (2021) A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation. Brief Bioinform 22(2): 1476-1498.

Sethi A, Joshi K, Sasikala K, Alvala M (2019) Molecular docking in modern drug discovery: Principles and recent applications. In: Drug Discovery and Development - New Advances. Gaitonde V, Karmakar P, Trivedi A (eds.). Intechopen.

Simpson C, Yamauchi Y (2020) Microtubules in influenza virus entry and egress. Viruses 12: 117.

Tian L, Pang Z, Li M, Lou F, An X, Zhu S, Fan J (2022) Molnupiravir and its antiviral activity against COVID-19. Front Immunol 13: 855496.

Uddin M, Mustafa F, Rizvi TA, Loney TA, Suwaidi H, Senok AC (2020) SARS-CoV-2/COVID-19: Viral genomics, epidemiology, vaccines, and therapeutic interventions. Viruses 12: 526.

Van ELE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, Kolundzic N, Abdulle AE, Van D, Voort PH, Olde RMG, Hoeven JG, Dunnen WF, Hillebrands JL, Goor VH (2021) COVID-19: Immunopathology, pathophysiological mechanisms, and treatment options. J Pathol 254: 307–331.

Wang Q, Wu J, Wang H, Gao Y, Liu Q, Mu A, Ji W, Yan L, Rao Z (2020) Structural basis for RNA replication by the SARS-CoV-2 polymerase. Cell 182: 417–428.

Yoshimoto FK (2020) The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J 39(3): 198–216.

© 2024 Journal of Pharmacy & Pharmacognosy Research

Biofilms related to periodontal disease
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 911-928, Sep-Oct 2024. DOI: Review Research trends in the study of biofilms related to periodontal disease: A bibliometric analysis [Tendencias de investigación en el estudio de las biopelículas relacionadas con la enfermedad periodontal: Un análisis bibliométrico] Julio C. Romero-Gamboa1, Melissa Pinella-Vega1, Pablo A. Millones-Gómez1, John … Continue reading Biofilms related to periodontal disease
Piceatannol-rich extract from Passiflora edulis and hyperpigmentation
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 900-910, Sep-Oct 2024. DOI: Original Article Piceatannol-rich extract from Passiflora edulis Sims seeds attenuates morphological differentiation through the reduction of MITF mRNA expression and F-actin polymerization in UVB-induced hyperpigmented B16F10 cells [El extracto rico en piceatannol de las semillas de Passiflora edulis Sims atenúa la … Continue reading Piceatannol-rich extract from Passiflora edulis and hyperpigmentation
Immunostimulatory effect of a nature-derived capsule
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 892-899, Sep-Oct 2024. DOI: Original Article Potential effects of Linh Loc Son hard capsule – a Vietnamese herbal combination in immunodeficiency induced by cyclophosphamide on mice [Efectos potenciales de la cápsula dura Linh Loc Son, una combinación de hierbas vietnamitas en la inmunodeficiencia inducida por … Continue reading Immunostimulatory effect of a nature-derived capsule

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio